CASE 2

Marcia Angell, editor in chief of the New England Journal of Medicine from 1999 to 2000 believes “oversight of clinical trials is too important to leave in the hands of drug companies and their agents.” ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download